1. The Board shall adopt regulations prescribing the training that a podiatric physician must receive before injecting:
- (a) A neuromodulator that is derived from Clostridium botulinum;
- (b) A neuromodulator that is biosimilar to or the bioequivalent of a neuromodulator described in paragraph (a); or
- (c) Dermal or soft tissue fillers.
- 2. A podiatric physician who has received the training prescribed pursuant to subsection 1 shall present proof of such training upon the request of a patient or any state or local governmental agency or agent thereof.
- 3. As used in this section “dermal or soft tissue filler” has the meaning ascribed to it in NRS 629.086.
(Added to NRS by 2017, 1262)